Publication date: Jan 15, 2025
Background: COVID-19 is currently one of the most important medical challenges as it affects the entire population, with children being infected as easily as adults. The objective of this study was to evaluate the prevalence of mortality in under 19-year-old individuals compared to that of adults. This retrospective, observational study analyzed the medical records of all patients diagnosed with COVID-19 by real-time reverse transcription-polymerase chain reaction (RT-PCR) who were hospitalized at Hospital de Base and the Infant and Maternal Hospital of ScE3o Jose do Rio Preto, SP, Brazil. Of a total of 8986 hospitalized COVID-19 positive patients, 383 were under 19 years old (Group I) and 8603 were adults (Group II). Overall mortality was significantly higher (p-value < 0. 0001) in Group II (n = 2185; 25. 4%) compared to Group I (n = 12; 3. 13%). Eleven of the 12 patients of Group I that died had associated diseases. The number of deaths of under 1-year-old infants was 2/123 (1. 63%), of 1- to 4-year-old children it was 4/95 (4. 21%), of 5- to 9-year-old children it was 1/47 (2. 13%), of 10- to 14-year-old adolescents it was 1/40 (2. 50%) and of 15- to 19-year-old adolescents it was 4/78 (5. 13%). Mortality from COVID-19 in children and adolescents was significantly lower than in adults and associated with other comorbidities.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Brazil | Adolescents |
| Hospitalization | Adults |
| Parent | Background |
| Brazil | |
| Compared | |
| Covid | |
| Group | |
| Hospital | |
| Hospitalization | |
| Hospitalized | |
| Important | |
| Mortality | |
| Old | |
| Retrospective | |
| Year |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| drug | DRUGBANK | Ribostamycin |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | hypertension |
| disease | MESH | ischemic heart disease |
| disease | MESH | vascular disease |
| disease | MESH | renal failure |
| disease | MESH | obesity |
| disease | MESH | dyspnea |
| disease | MESH | dementia |
| disease | MESH | death |
| disease | MESH | defects |
| disease | MESH | syndrome |
| disease | MESH | metabolic acidosis |
| disease | MESH | hyperlactatemia |
| disease | MESH | hyperglycemia |
| disease | MESH | hypoproteinemia |
| disease | MESH | anemia |
| disease | MESH | ketoacidosis |
| disease | MESH | infection |
| disease | MESH | critical illness |
| disease | MESH | congenital heart disease |
| disease | MESH | asthma |
| pathway | KEGG | Asthma |
| disease | MESH | morbidity |
| disease | MESH | comorbidity |
| disease | MESH | relapse |
| disease | MESH | viral infections |